STARTUP PROFILE

Surf Therapeutics

COUNTRY
USA
FOUNDED
2023
CATEGORY
Neuromodulation
Developing a non-invasive ultrasound neuromodulation platform designed to engage the body’s anti-inflammatory neural pathways for treatment of chronic inflammatory disorders.
Visit website →

Track this company in Market Notes

Funding, launches and regulatory moves across the neurotech startup map, delivered every two weeks.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Ultrasound
FORM FACTOR
Other
INTERFACE DEPTH
Non-invasive
INDICATION
Other
TARGET USER
Patients
REGULATORY STAGE
Investigational
Surf Therapeutics is developing ultrasound-based neuromodulation aimed at anti-inflammatory neural pathways, making it more adjacent to bioelectronic medicine than central neurotechnology. Its ultrasound approach is distinctive, though still early.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Surf Therapeutics
No items found.